The Economics of Robotic Cystectomy: Cost Comparison of Open versus Robotic Cystectomy Douglas Scherr, MD.

Slides:



Advertisements
Similar presentations
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
Advertisements

Urostomy Why? Patricia Anderson BSN RN CWOCN. The American Cancer Society’s estimates for bladder cancer in the United States for 2013 are: About 72,570.
The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer ChartbookAugust 2014.
SHORT-TERM PATIENT REPORTED QUALITY OF LIFE AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY USING THE CONVALESCENCE AND RECOVERY EVALUATION (CARE) Abid Hussain.
ROBOTIC MYOMECTOMY Dr Rooma Sinha, MD, DNB
Alphabet soup. Alphabet soup Reasons for Hysterectomy FOCUS: HYSTERECTOMY Definition Types of Hysterectomy Reasons for Hysterectomy Surgical Options.
Trials in gastric cancer surgery Presenter Dr Pankaj Kumar Garg Moderator Dr Sunil Kumar.
What is the place of the Artificial Urinary Sphincter in 2012? Introduction There are an increasing array of surgical options for the treatment of post-prostatectomy.
Surgical Management of Invasive Bladder Cancer
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
The Maturation of a Specialty: Workforce Projections for Endocrine Surgery Julie Ann Sosa, MA, MD, FACS Associate Professor of Surgery Sections of Oncologic.
Mallat F, Hmida W, Hidoussi A, Tlili G, Slama A, Jaidane M, Ben Sorba N, Mosbah AF Ben Abdallah A, Mama N Department of urology and radiology, CHU Sahloul,
Adult Medical-Surgical Nursing
Ileal neobledder without ureteroileal stents- preventing of postoperative urinary tract infection. P. Kowal, T. Szydełko, J. Dembowski, J. Sokołowski,
Radical cystectomy in patients over 70 J.Sokołowski, T. Szydełko, P.Kowal, W.Kołaczyk, J.Dembowski, W.Dobrucki, R.Zdrojowy, A.Kołodziej, M.Fiutowski, M.Belda,
Prostate Cancer Treatment: What’s Best For You?
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Dr. Abdellatif Zayed Bladder Cancer.
Urinary Diversion: Does RARC learning curve affect diversion choice in urothelial carcinoma PG O’Malley 1, B Al Hussein Al Awamlh 1, DP Nguyen 1, BM Faltas.
Advances in Robotic Surgery:
Neoplasms of the bladder
Weill Cornell Robotic Cystectomy Costing Study Douglas S. Scherr, MD Department of Urology The New York Presbyterian Hospital Weill Medical College of.
A Comparative Analysis of Quality of Life of Patients Treated by Radical Cystectomy and Sigmoid Neobladder versus Chemoradiation in Muscle Invasive Cancer.
Trends in Regionalization of Inpatient Care for Urological Malignancies Matthew R. Cooperberg Sanjukta Modak Badrinath R. Konety Department of Urology.
Andrzej Sieskiewicz Department of Otolaryngology Medical University Of Bialystok, Poland Decreased Hemodynamic Parameters During Endoscopic Procedures.
Minimally Invasive Approaches in the Treatment of Urothelial Carcinoma “Robotic Radical Cystectomy” Douglas S. Scherr, M.D. Weill Medical College of Cornell.
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
Introduction & Objectives Using strict criteria, solitary muscle invasive TCC of the bladder can be managed favorably in a bladder sparing manner with.
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Robot-assisted Laparoscopic Radical Cystectomy KH Rha Severance Hospital Yonsei University The 10 th Catholic International Urology Symposium, :30–14:50.
UOG Journal Club: April 2014 Comparison of vaginal mesh repair with sacrospinous vaginal colpopexy in the management of vaginal vault prolapse after hysterectomy.
ROBOTIC VERSUS LAPAROSCOPIC SLEEVE GASTRECTOMY FOR MORBID OBESITY: A META-ANALYSIS Background Results Methods Conclusion Kandace Kichler, MD; Jessica L.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Trends in Financial and Operating Performance of Rehabilitation Hospitals Under the Rehabilitation Prospective Payment System Jon M. Thompson, Ph.D. Professor.
Short-term Effect of Radical Hysterectomy with or without Adjuvant Radiation Therapy on Urodynamic Parameters in Patients with Uterine Cervical Cancer.
Appendicitis: Challenges in Management
Advances in Robotic Surgery for Improved Patient Care
Laparoscopic surgery for rectal cancer What is the evidence?
Robotic surgery in urology
Esophagectomy for cancer:
Gregory Sturz1, Howard Gutgesell2, Mark Conaway3 and Peter Dean2
CCO Independent Conference Highlights
Title Introduction Methods Results Discussion Authors
135th Annual Meeting of APHA, November 3-7, 2007 Washington DC Session
Management of Invasive Bladder Cancer
Urinary Tract Infections in Patients With Urinary Diversion
A Monocentric Experience among a multidisciplinary team
Advancing Gynaecological Surgery:
Figure 4 Types of urinary diversion
Jose D Roman M.D. Braemar Hospital, Hamilton, NEW ZEALAND
Volume 66, Issue 2, Pages (August 2014)
“Tecniche chirurgiche a confronto”
International Journal of Surgery
Apollo Gleneagles Hospitals,
Volume 68, Issue 3, Pages (September 2015)
Volume 73, Issue 3, Pages (March 2018)
Liverpool Heart and Chest Hospital
Urinary Tract Infections in Patients With Urinary Diversion
Is a shortened length of stay and increased rate of discharge to home associated with a low readmission rate and cost-effectiveness after primary total.
Frederick L Grover, MD  The Annals of Thoracic Surgery 
Jimmy Nguyen and Paul Arnold, M.D.
What is the marginal cost for marginal risk in cardiac surgery?
Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery  Scott M. Damrauer, MD, Ann C. Gaffey, MD, Ann.
Taking Control of Your Surgery: Impact of a Prehabilitation Program on Major Abdominal Surgery  Ryan Howard, MD, Yue S. Yin, BS, Lane McCandless, BS,
Damien J. LaPar, MD, MS, James M. Isbell, MD, MSCI, Daniel P
Is a shortened length of stay and increased rate of discharge to home associated with a low readmission rate and cost-effectiveness after primary total.
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
National data in surgery: LCCOP 2018(2016)
PowerPoint 16:9 Screen Ratio Template *
Presentation transcript:

The Economics of Robotic Cystectomy: Cost Comparison of Open versus Robotic Cystectomy Douglas Scherr, MD

Background Treatment for recurrent CIS, high grade T1, or muscle invasive bladder carcinoma includes radical cystectomy with extended pelvic lymph node dissection and urinary diversion

Background What is the economic impact of open vs. robotic cystectomy with urinary diversion? Peri- and postoperative cost outcome data from prospectively maintained database of consecutive radical cystectomies (62 open, 41 robotic)

Methods Methods Costing Direct: professional, facility, and anesthesia fees Procedural costs: defined by 50th percentile of Medicare Resource Based Relative Value Scale (RBRVS) Cost of equipment ($1M) and annual service contract ($100k) (da Vinci Surgical System, Intuitive Surgical, Inc.) amortized over 7 years with Cornell 3 year avg case volume (269 cases per year) → robotic cost burden of $3,488 per case Indirect: cost of complications Complication rates derived from Cornell prospectively maintained database for any readmission or treatment during 90 day global period

Data Data Category Open Robotic Surgeon Fee ($) Ileal conduit $7,694 Continent cutaneous diversion Neobladder $8,449 Anesthesia Time (hr) 7.0 7.8 6.4 6.7 8.0 9.2 Neobladder* 7.6 9.3 * denotes p < 0.05

Data Data Category Open Robotic PACU Time (hr) 11.1 16.3 Ileal conduit* 9.8 16.5 Continent cutaneous diversion 16.4 15.3 Neobladder 9.7 Length of Stay (d) 11.4 7.2 10.6 7.5 15.6 8.6 Neobladder* 10.0 6.2 * denotes p < 0.05

Data Data Category Open Robotic Avg Complication Rate (%)* 30.6% 19.5% Ileal conduit* 42.4% 8.3% Continent cutaneous diversion 16.7% 25.0% Neobladder 17.6% 38.5% Complication Length of Stay (d) 17.2 13.8 17.5 18.0 13.0 8.0 Neobladder* 18.3 13.2 * denotes p < 0.05

Results Urinary Diversion Open Robotic Ileal conduit $154,276 $90,472 Direct $98,445 $79,015 Indirect $55,831 $11,457 Continent cutaneous diversion $155,222 $105,203 $138,925 $90,245 $16,297 $14,958 Neobladder $120,601 $111,111 $96,820 $72,843 $24,321 $38,267

Results The impact of decreased length of stay (LOS) with robotic cystectomy outweighs the marginal cost impact of a da Vinci robotic system!

Sensitivity Analysis Minimum number of annual robotic cases to maintain cost equivalence to open cystectomy? Ileal conduit: 4 cases ($150,282) Continent cutaneous diversion: 5 cases ($152,870) Orthotopic neobladder: 23 cases ($120,766) Maximum LOS for open cystectomy to achieve cost equivalence to robotic cystectomy? Ileal conduit: 2.0 days Continent cutaneous diversion: 8.9 days Orthotopic neobladder: 8.8 days

Conclusions Robotic cystectomy appears more cost-effective than open cystectomy for treatment of bladder cancer Majority of improvement driven by lower LOS High initial materials cost of robotic surgery defrayed by subsequent cost savings during hospitalization Annual robotic volume does not need to be high (<25 cases per year) to justify use of robotic cystectomy Cost savings of robotic cystectomy however is diminished with decreased open cystectomy LOS (2 to 9 days)